- The journal
- nike dunk armor buy , Cut in half: Nike Metcon 9 Review (2024) , AspennigeriaShops
- air jordan 1 royal nike outlet
- The 25 Best Air Force basketball 1 Colourways of All Time , IetpShops , Nike Swoosh logo embroidered fleece shorts
- Adidas x Pharrell NMD HU Gold - adidas Nizza Platform Mid Parley Almost Blue W Release Date - SBD
- nike flyknit roshe electric green black Paris 308270 - SBD - nike boot with side zipper jeans black pants size , 111 Release Date
- air jordan 1 mid crater grey
- NBA x Nike Dunk Low 75th Anniversary
- adidas y 3 qasa high triple black
- Air Jordan 5 Racer Blue CT4838 004 Release Date Price 4
- Air Jordan 1 Heritage 555088 161 Release Date On Foot
- Aims & Scope
- Editorial Policies and Processes
- Scientific and Methodological Rigor
- Production and Administration
- Committees
- Authors
- Ethical Considerations
- Submit Article
- Archive
- Indexation
- Search
- Contact us
Farm Comunitarios. 2024 Jan 15;16(1):51-54. doi: 10.33620/FC.2173-9218.(2024).05
The review of the treatment of a very complex patient easily finds areas for improvement. Case report
Parras L. The review of the treatment of a very complex patient easily finds areas for improvement. Case report. Farm Comunitarios. 2024 Jan 15;16(1):51-54. doi: 10.33620/FC.2173-9218.(2024).05
Abstract :
Case presentation. A 100-year-old male presented with an episode of profound bradycardia. The patient’s carer alerted the emergency department and they withdrew the bisoprolol and controlled the bradycardia. Once the problem was resolved, we were asked if any of his medications could be related to the bradycardia.
Assessment and evaluation. On reviewing all the patient’s treatment, which is very complex, we cannot establish a clear relationship between any of his 19 drugs and the bradycardia, except for the bisoprolol already withdrawn, but we found 6 other problems that we tried to solve.
Results. Of the 6 proposed changes, 3 are accepted.
Final comment. The review of a complex treatment will probably allow us to detect some aspects that could be improved.
Keywords :
Frail Elderly, polypharmacy
Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria.
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
-
Manual for authors
Journal Information
Last update of farmaceuticoscomunitarios.org : 16.01.2024
Copyright © (Sociedad Española de Farmacia Clínica, Familiar y Comunitaria) |
ISSN Digital edition: 2173-9218
Journal committees - Legal notice - Privacy policy - Cookies policy - Advertising policy
e-mail: soporte@sefac.org | Responsible for this web site: Jordi Serrano Valdés
Development, Web design & computer programming: Edittec |
The information provided on this site is intended to complement and not to replace the
relation between a patient and his or her existing physician.
This work is under Creative Commons licence Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional licence.